Please login to the form below

Not currently logged in
Email:
Password:

Novira Therapeutics

This page shows the latest Novira Therapeutics news and features for those working in and with pharma, biotech and healthcare.

J&J buys firm seeking hepatitis B cure

J&J buys firm seeking hepatitis B cure

Acquires Philadelphia-based Novira therapeutics. Johnson &Johnson (J&J) has agreed to buy a Pennsylvania biotech company that is trying to develop treatments to cure hepatitis B virus (HBV) infection. ... Terms of the acquisition of Philadelphia-based

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Latest appointments

  • Christian Schade joins Aprea AB Christian Schade joins Aprea AB

    Most recently, Schade served as chief executive officer of Novira Therapeutics, which was acquired by Johnson &Johnson at the end of last year.

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Merrill Brink International

Merrill Brink International is a leading provider of life sciences, legal, financial, manufacturing and corporate language solutions for global companies....

Latest intelligence

Not another weight-loss ad
Christmas is over and the gyms are packed, it’s a never-ending tale. But why do we do it to ourselves every year?...
China’s clinical trial shake-up
As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...
Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...

Infographics